Biogen to Report Second Quarter 2017 Financial Results and Strategic Update on July 25, 2017
21 June 2017 - 6:01AM
Business Wire
Biogen Inc. (NASDAQ:BIIB) today announced it will report second
quarter 2017 financial results and a strategic update on Tuesday,
July 25, 2017, before the financial markets open.
Following the release of the financials, the Company will host a
live webcast with Biogen management from 8:00-9:30 am ET. To access
the live webcast, please go to the investor relations section of
Biogen’s website at www.biogen.com/investors. Following the live
webcast, an archived version of the call will be available at the
same URL.
About BiogenThrough cutting-edge science and medicine,
Biogen discovers, develops and delivers innovative therapies
worldwide for people living with serious neurological and
neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in
biotechnology and today the Company has the leading portfolio of
medicines to treat multiple sclerosis, has introduced the first and
only approved treatment for spinal muscular atrophy, and is at the
forefront of neurology research for conditions including
Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral
sclerosis. Biogen also manufactures and commercializes biosimilars
of advanced biologics. For more information, please visit
www.biogen.com. Follow us on social media – Twitter, LinkedIn,
Facebook, YouTube.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170620005997/en/
BiogenKaren Jewell, 781-464-2442Investor Relations
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From Apr 2024 to May 2024
Biogen (NASDAQ:BIIB)
Historical Stock Chart
From May 2023 to May 2024